Lexicon Pharmaceuticals, Inc.
NASDAQ:LXRX
1.27 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1.204 | 0.139 | 0.298 | 23.995 | 322.073 | 63.209 | 90.335 | 83.337 | 130.014 | 22.854 | 2.222 | 1.089 | 1.849 | 4.908 | 10.7 | 32.321 | 50.118 | 72.798 | 75.68 | 61.74 | 42.838 | 35.2 | 305.577 | 14.459 | 4.7 |
| Cost of Revenue
| 0.639 | 0.427 | 55.046 | 1.929 | 3.231 | 2.491 | 1.899 | 163.973 | 95.187 | 89.279 | 89.682 | 82.574 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.621 | -2 |
| Gross Profit
| 0.565 | -0.288 | -54.748 | 22.066 | 318.842 | 60.718 | 88.436 | -80.636 | 34.827 | -66.425 | -87.46 | -81.485 | 1.849 | 4.908 | 10.7 | 32.321 | 50.118 | 72.798 | 75.68 | 61.74 | 42.838 | 35.2 | 305.577 | 17.08 | 6.7 |
| Gross Profit Ratio
| 0.469 | -2.072 | -183.718 | 0.92 | 0.99 | 0.961 | 0.979 | -0.968 | 0.268 | -2.906 | -39.361 | -74.826 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1.181 | 1.426 |
| Reseach & Development Expenses
| 58.333 | 52.816 | 55.046 | 153.621 | 91.924 | 100.243 | 156.813 | 178.151 | 95.187 | 89.279 | 89.682 | 82.574 | 91.828 | 75.35 | 81.238 | 108.575 | 104.332 | 106.695 | 93.625 | 90.586 | 82.198 | 74.859 | 53.355 | 31.647 | 14.6 |
| General & Administrative Expenses
| 0 | 48.083 | 0 | 0 | 0 | 63.754 | 66.203 | 43.044 | 23.835 | 19.411 | 17.121 | 17.043 | 17.35 | 22.566 | 19.418 | 20.281 | 20.74 | 21.334 | 0 | 0 | 0 | 0 | 20.861 | 18.289 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 113.982 | 48.083 | 32.342 | 47.23 | 56.835 | 63.754 | 66.203 | 43.044 | 23.835 | 19.411 | 17.121 | 17.043 | 17.35 | 22.566 | 19.418 | 20.281 | 20.74 | 21.334 | 18.174 | 18.608 | 23.233 | 23.234 | 20.861 | 18.289 | 2.9 |
| Other Expenses
| -58.887 | 0 | 0 | 1.6 | 28.638 | 0 | 1.954 | 2.293 | 0.572 | 2.255 | 0.059 | 0.105 | 24.116 | 2.71 | 0 | 20.281 | 20.74 | 21.334 | 18.174 | 18.608 | 23.233 | 23.234 | 275 | 2.621 | 4.9 |
| Operating Expenses
| 172.315 | 100.899 | 87.388 | 200.851 | 148.759 | 163.997 | 223.016 | 221.195 | 119.022 | 108.69 | 106.803 | 99.617 | 115.944 | 100.626 | 100.656 | 128.856 | 125.072 | 128.029 | 111.799 | 109.194 | 105.431 | 98.093 | 349.216 | 52.556 | 19.5 |
| Operating Income
| -171.75 | -100.76 | -87.09 | -178.785 | 141.445 | -103.279 | -136.681 | -137.155 | 1.468 | -100.366 | -102.371 | -108.415 | -114.095 | -95.718 | -89.956 | -96.535 | -74.954 | -55.231 | -36.119 | -47.454 | -62.593 | -62.893 | -43.639 | -35.477 | -12.8 |
| Operating Income Ratio
| -142.65 | -724.892 | -292.248 | -7.451 | 0.439 | -1.634 | -1.513 | -1.646 | 0.011 | -4.392 | -46.072 | -99.555 | -61.706 | -19.502 | -8.407 | -2.987 | -1.496 | -0.759 | -0.477 | -0.769 | -1.461 | -1.787 | -0.143 | -2.454 | -2.723 |
| Total Other Income Expenses Net
| -5.369 | -1.184 | -0.668 | 120.211 | -17.326 | -17.269 | -2.101 | 0.703 | -9.524 | -14.53 | 2.269 | -9.782 | 0.153 | -3.883 | -1.377 | -3.42 | -0.794 | 0.401 | 0.558 | 1.304 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -177.119 | -101.944 | -87.758 | -58.574 | 124.119 | -120.548 | -141.711 | -141.429 | -4.682 | -100.364 | -104.126 | -110.211 | -116.215 | -101.801 | -93.419 | -96.884 | -71.233 | 54.43 | 39.196 | -46.15 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax Ratio
| -147.109 | -733.41 | -294.49 | -2.441 | 0.385 | -1.907 | -1.569 | -1.697 | -0.036 | -4.392 | -46.861 | -101.204 | -62.853 | -20.742 | -8.731 | -2.998 | -1.421 | 0.748 | 0.518 | -0.747 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.386 | 1.184 | 0.51 | 11.61 | -6.014 | 3.508 | -12.661 | 4.511 | 5.995 | -0.07 | -0.833 | -1.971 | -2.359 | -0.026 | -0.102 | -19.675 | -16.16 | -0.119 | 0.119 | -0.282 | 1.605 | -3.223 | -8.467 | -9.483 | -0.3 |
| Net Income
| -177.119 | -103.128 | -88.268 | -70.184 | 130.133 | -120.548 | -129.05 | -141.429 | -4.682 | -100.294 | -104.126 | -110.211 | -116.215 | -101.775 | -82.78 | -76.86 | -58.794 | -54.311 | -36.315 | -47.172 | -64.198 | -59.67 | -35.172 | -25.994 | -12.5 |
| Net Income Ratio
| -147.109 | -741.928 | -296.201 | -2.925 | 0.404 | -1.907 | -1.429 | -1.697 | -0.036 | -4.388 | -46.861 | -101.204 | -62.853 | -20.737 | -7.736 | -2.378 | -1.173 | -0.746 | -0.48 | -0.764 | -1.499 | -1.695 | -0.115 | -1.798 | -2.66 |
| EPS
| -0.8 | -0.62 | -0.61 | -0.63 | 1.23 | -1.14 | -1.23 | -1.36 | -0.045 | -1.31 | -1.42 | -1.58 | -2.39 | -2.35 | -3.98 | -3.93 | -4.12 | -5.68 | -3.97 | -5.21 | -7.91 | -7.99 | -4.9 | -4.37 | -3.57 |
| EPS Diluted
| -0.8 | -0.62 | -0.61 | -0.63 | 1.11 | -1.14 | -1.23 | -1.36 | -0.045 | -1.31 | -1.42 | -1.58 | -2.39 | -2.35 | -3.98 | -3.93 | -4.12 | -5.68 | -3.97 | -5.21 | -7.91 | -7.99 | -4.9 | -4.37 | -3.57 |
| EBITDA
| -171.196 | -99.164 | -86.956 | -176.018 | 173.433 | -99.771 | -132.626 | -135.565 | 11.564 | -83.581 | -104.365 | -98.21 | -113.84 | -95.199 | -89.076 | -83.045 | -63.738 | -44.431 | -25.042 | -35.886 | -41.063 | -42.314 | -27.089 | -32.856 | -10.8 |
| EBITDA Ratio
| -142.189 | -713.41 | -291.799 | -7.336 | 0.538 | -1.578 | -1.468 | -1.627 | 0.089 | -3.657 | -46.969 | -90.184 | -61.568 | -19.397 | -8.325 | -2.569 | -1.272 | -0.61 | -0.331 | -0.581 | -0.959 | -1.202 | -0.089 | -2.272 | -2.298 |